Official Publications Johnson & Johnson Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 16:36:28 25/05/2023 BST			5-day change	1st Jan Change
136 ^USD	-0.73%		-0.73%	-.--%

06-15	Johnson & Johnson Announces Late-Breaking Results Show nipocalimab Significantly Improves Sjögren's Disease Activity in A Phase 2 Study	CI
06-14	EU regulator mandates label updates on CAR-T cancer therapies	RE

SEC Filing 8K	05-19	CO
SEC Filing 8K	05-16	CO
SEC Filing 8K	04-30	CO
SEC Filing 10Q-1	04-30	CO
Shareholders meeting voting results	04-24	CO
SEC Filing 8K	04-15	CO
Slide show Q1	04-15	CO
1st quarter results	04-15	CO
SEC Filing 13G	04-09	CO
Proxy Statments	03-12	CO
SEC Filing 10K	02-15	CO
SEC Filing 13G	01-23	CO
SEC Filing 8K	01-22	CO
Slide show results	01-22	CO
Annual results	01-22	CO
SEC Filing 8K	12-04	CO
SEC Filing 8K	11-29	CO
SEC Filing 8K	11-20	CO
SEC Filing 10Q-3	26/10/23	CO
SEC Filing 8K	19/10/23	CO
Slide show Q3	16/10/23	CO
3rd quarter results	16/10/23	CO
SEC Filing 8K	16/10/23	CO
SEC Filing 8K	29/08/23	CO
SEC Filing 8K	22/08/23	CO

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm